Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
Noura J. Choudhury, Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon, Pier Selenica, Adam J. Schoenfeld, Natasha Rekhtman, Daniel R. Gomez, Michael F. Berger, Marc Ladanyi, Maria E. Arcila, Charles M. Rudin, Gregory J. Riely, Mark G. Kris, Glenn Heller, Jorge S. Reis‐Filho, Helena A. Yu
Topics & Concepts
OsimertinibMedicineAcquired resistanceMutantDiseaseLung cancerFirst lineLung diseaseOncologyLungCancer researchInternal medicineEpidermal growth factor receptorCancerGeneticsGeneBiologyErlotinibLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment